Search
Login
Register
Menu
Latest issue
Home
News
CongressUpdate
Guidelines
Specials
Links
Reimbursement News
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: Caplacizumab, a game changer in the treatment of acquired thrombotic thrombocytopenic purpura
“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart.
View cart
Article: Caplacizumab, a game changer in the treatment of acquired thrombotic thrombocytopenic purpura
€
3.03
Article: Caplacizumab, a game changer in the treatment of acquired thrombotic thrombocytopenic purpura quantity
Add to cart
SKU:
product-article-25364
Category:
General
Description
Description
Caplacizumab, a game changer in the treatment of acquired thrombotic thrombocytopenic purpura
Related products
Article: Calendar of events
€
3.03
Add to cart
1 year access Online Belgian Journal of Hematology (BJH)
€
71.94
Add to cart
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€
3.03
Add to cart
Article: Highlights in urologic cancer
€
3.03
Add to cart